Deutsche Bank’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
Deutsche Bank's CLPT Position: Q3 2026 in Review
Deutsche Bank reduced its ClearPoint Neuro (CLPT) stake by 2.6% in Q3 2026, selling an estimated $45.2K and leaving 111,786 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.
Deutsche Bank first reported a position in CLPT in Q2 2021 and has held it in 15 quarters since. The position peaked at $5.06M in Q3 2025. 45 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- Deutsche Bank held 111,786 shares of ClearPoint Neuro worth $1.36M as of Q3 2026.
- Deutsche Bank sold 3,009 ClearPoint Neuro shares in Q3 2026, an estimated $45.2K.
- ClearPoint Neuro made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2017 holding.
- Deutsche Bank first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 15 quarters since.
- Deutsche Bank's ClearPoint Neuro position peaked at $5.06M in Q3 2025.
- 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.